Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences experienced notable insider activity recently, with CEO Ivor Elrifi executing three consecutive open-market purchases totaling approximately $985,909. These acquisitions occurred early August, shortly before the latest earnings report. Despite this executive buying, the stock price remains near its fifty-two-week low, reflecting a 20.9% decline over the preceding ninety-day period.
Ticker: TLSA Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tiziana Life Sciences Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
263.56
Quantity 35,692 +25.7%
Value US$3,196,923
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
121.64
Quantity 29,140 -4.1%
Value US$1,869,742
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
77.19
Quantity 87,030 +5.2%
Value US$4,285,570
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-06 2026-08-05 B Purchase

Chief Executive Officer

Officer
35,692 +25.7%
263.56
US$3,196,923
35,692 +25.7% 263.56 US$3,196,923
2026-08-06 2026-08-04 B Purchase

Chief Executive Officer

Officer
29,140 -4.1%
121.64
US$1,869,742
29,140 -4.1% 121.64 US$1,869,742
2026-08-05 2026-08-03 B Purchase

Chief Executive Officer

Officer
87,030 +5.2%
77.19
US$4,285,570
87,030 +5.2% 77.19 US$4,285,570